Will Omicron be the Grinch who steals the Christmas party this year? Fearing to relive the scenario of spring 2020, Asian, European and American investors made massive stock market releases on Monday. Down 1.12% on Friday, Cac 40 again lost 0.82%, to 6,870.10 points, in a large transaction volume of 4 billion euros. At the low of the day, the Parisian index even fell to 6,747.69 points, before the Moderna laboratory announced that the injection of a third dose of 50 micrograms of its vaccine increased resistance to the Omicron variant by 37. . The antibody level is even multiplied by 83 in the case of a dose of 100 micrograms. Across the Atlantic, the Dow jones and the Nasdaq Composite bend by 1.8%. Quite logically, the values of transport and tourism have triumphed, likeAir France-KLM (-0.97%). Commercial real estate Unibail-Rodamco-Westfield was also under pressure, ending down 2.37%. same for me Klépierre and Gecina. A few rare stocks ended up on the rise, such as the world number one in bioanalysis Eurofins Scientific (+ 2.59%).
All-round health restrictions
Faced with the Omicron surge, which could become the majority by mid-January in Europe, health restriction measures are increasing. On Sunday, the Netherlands reintroduced strict containment until mid-January while France decided to curb outdoor festivities in the Christmas-New Year period. There will be no fireworks on December 31 in Paris. Italy, she could impose the wearing of the mask outside and would consider a shortening of the validity of vaccine passports. The first travel restrictions have been announced: Ireland, Portugal, Italy and Greece now require Europeans, even vaccinated, to present a negative test on their arrival. Germany will for its part impose a period of quarantine on unvaccinated travelers from France and Denmark. Berlin has classified the UK as a “high risk” country.
Aware that the recovery will be under stress, the Banque de France has adjusted its growth forecast for 2022, now anticipating an increase in gross domestic product of 3.6%, against 3.7% previously and 6.7% in 2021. Un a more conservative figure than the 4% put forward by the government, but this is the central assumption. The dark scenario is based on a GDP increase of only 2.2% in 2022, accompanied by a strong rebound in 2023, estimated at 3.6%. Across the Atlantic, Goldman Sachs also pulled out its calculator, downgrading its growth expectations for 2022, after Democratic Senator Joe Manchin announced that he will not support the $ 1.750 billion social spending bill of Joe biden. ” We were already expecting an unfavorable fiscal boost for 2022 due to weakening support against the Covid-19 brought in 2020 and 2021 and without the enactment of the ‘BBB’, this budget boost will become a little more unfavorable than expected Goldman Sachs analyst Jan Hatzius wrote in a note dated Sunday. He expects GDP to increase by 2% in the first quarter of 2022, up from 3% so far.
Ipsen heckled
Among other values, BNP Paribas gained 0.45%. The establishment will sell its subsidiary Bank of the West, which operates its commercial banking activities in the United States, to the Bank of Montreal for an amount exceeding expectations of $ 16.3 billion, or approximately 14.5 billion dollars. Billions of Euro’s.
Finally, Ipsen again dropped 7.36% after the green light from the US health authority for marketing by the Indian laboratory Cipla for its lanreotide treatment, a generic of Somatulin, flagship product of the French group.